Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Multiple Sclerosis and Related Disorders|July 13, 2021
Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8aPaul Kamudoni, Jeffrey Johns, Karon F Cook, et al.
Therapeutic Advances in Neurological Disorders|April 2, 2021
Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 studyAnnette Wundes, Sibyl Wray, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS studyVictoria M Leavitt, Robert Fox, Jop Mostert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 23, 2020
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosisGuy Buckle, Daniel Bandari, Jeffrey Greenstein, et al.
Multiple Sclerosis and Related Disorders|May 22, 2022
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosisPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Neurodegenerative Disease Management|July 26, 2024
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summaryPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Journal of the Neurological Sciences|November 19, 2024
Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosisSergey A Kornilov, Nathan D Price, Richard Gelinas, et al.
Frontiers in Neurology|June 26, 2023
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosisRebecca I Spain, Andrea Hildebrand, Carin S Waslo, et al.
Pageof 5